A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer

BACKGROUND: Randomized phase II and III studies showed the promising results of the combination of carboplatin/pemetrexed with pembrolizumab in non-squamous non-small cell lung cancer patients. Patients with brain metastases were excluded from the phase II study. After FDA approval, this regimen was...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Thorac Dis
Prif Awduron: Afzal, Muhammad Zubair, Dragnev, Konstantin, Shirai, Keisuke
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2018
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6051823/
https://ncbi.nlm.nih.gov/pubmed/30069355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.06.08
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg